Dengue-3 virus genomic differences that correlate with in vitro phenotype on a human cell line but not with disease severity.
We compared the full genome sequence of nine clinical isolates of dengue virus obtained during an epidemic of dengue-3 in French Polynesia in 1989, from patients with various presentations of disease. The isolates, all belonging to Genotype I, had 25 amino acid substitutions. There was no association with disease severity. When cultured in the K562 human erythroleukemia cell line, the isolates induced a range of cell growth inhibitions that was not associated with the degree of disease severity. By contrast, some substitutions--charge changes in NS1 and NS5, side-chain differences in NS1, loss of the E-153 potential glycosylation site, and 11 nucleotide insertions in the 3'UTR--that have been suggested to result in an increase or attenuation of dengue infection, appeared to be associated with the level of inhibition. These data represent the first documented study of an association between differences in the full dengue-3 genome of clinical isolates and the in vitro phenotype of these isolates on a human cell line.
Roche
Claudine
C
Laboratoire de Recherche en Virologie Médicale, Institut Louis Malardé, P.O. Box 30, 98713 Papeete, Tahiti, Polynésie Française.
Cassar
Olivier
O
Laille
Manola
M
Murgue
Bernadette
B
D000595:Amino Acid Sequence; D016384:Consensus Sequence; D003715:Dengue / Q000473:pathology* / Q000821:virology*; D003716:Dengue Virus / Q000235:genetics* / Q000302:isolation & purification / Q000472:pathogenicity; D016679:Genome, Viral; D006801:Humans; D020014:K562 Cells; D010641:Phenotype; D010802:Phylogeny; D012720:Severity of Illness Index